Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, April 14, 2026.
Arbutus Biopharma Corporation (NASDAQ:ABUS)
Long-Term Downtrend (-90) - ABUS is in a strong downtrend that is likely to continue. While ABUS is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid ABUS?
MarketClub looks at technical strength and momentum to determine if the timing is right for ABUS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for ABUS
The long-term trend has been DOWN since Jan 16th, 2026 at 4.080
The intermediate-term trend has been DOWN since Mar 19th, 2026 at 4.190
The short-term trend has been DOWN since Apr 7th, 2026 at 4.374
Smart Scan Analysis for ABUS
Based on our trend formula, ABUS is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 4.14 | 4.38 | 4.13 | 4.35 | +0.20 |
| Prev. Close | Volume | Bid | Ask | Time |
| 4.15 | 1213233 | 2026-04-13 15:59:41 |
| Year High | 12.6 | Year High Date | 2018-08-02 |
| Year Low | 4.01 | Year Low Date | 2018-10-15 |
| 52wk High | 5.1 | 52wk High Date | 2025-09-11 |
| 52wk Low | 2.94 | 52wk Low Date | 2025-05-15 |
| Average Volume | 1,965,796 | Shares Outstanding | 195,478 |
| Assets | 94,618,000M | Liabilities | 18,042,000M |
| Volatility | 102.46 |